Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for EPGNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2023 2.518M
March 31, 2023 7.101M
December 31, 2022 6.062M
September 30, 2022 4.934M
June 30, 2022 4.134M
March 31, 2022 3.728M
December 31, 2021 2.892M
September 30, 2021 3.218M
June 30, 2021 3.948M
March 31, 2021 3.549M
December 31, 2020 3.589M
September 30, 2020 3.853M
June 30, 2020 4.183M
March 31, 2020 7.987M
December 31, 2019 4.894M
September 30, 2019 4.402M
June 30, 2019 4.378M
March 31, 2019 3.225M
December 31, 2018 3.674M
September 30, 2018 11.74M
June 30, 2018 10.66M
March 31, 2018 11.08M
December 31, 2017 11.04M
September 30, 2017 11.09M
June 30, 2017 4.992M
Date Value
March 31, 2017 3.291M
December 31, 2016 4.006M
September 30, 2016 6.243M
June 30, 2016 9.532M
March 31, 2016 8.757M
December 31, 2015 5.975M
September 30, 2015 7.658M
June 30, 2015 7.140M
March 31, 2015 6.636M
December 31, 2014 6.307M
September 30, 2014 6.027M
June 30, 2014 6.848M
March 31, 2014 6.507M
December 31, 2013 6.369M
September 30, 2013 2.956M
June 30, 2013 2.405M
March 31, 2013 2.838M
December 31, 2012 3.586M
September 30, 2012 4.600M
June 30, 2012 3.949M
March 31, 2012 3.384M
December 31, 2011 4.254M
September 30, 2011 5.536M
June 30, 2011 3.915M
March 31, 2011 3.711M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
CureVac NV 314.18M
PAION AG --
Anbio Biotechnology --
Anika Therapeutics, Inc. 46.19M
Perspective Therapeutics, Inc. 68.16M